Successful management of claustrophobia and depression during allogeneic SCT.
As psychological problems are frequent in SCT patients we report on a patient with chronic myeloid leukemia, claustrophobia and depression. The successful allogeneic stem cell transplant of this patient in a reverse isolation setting required intensive interdisciplinary hematological, psychological and psychiatric collaboration. Psychopharmacologically the patient was treated with lorazepam 1 mg at 10 a.m. and 8 p.m. and after crisis on day +6, and 2.5 mg twice daily i.v. until one day before discharge (total 20 doses). Psychological counseling followed a cognitive-behavioural approach including progressive muscle relaxation and cognitive techniques focusing on the actual coping processes.
Kopp
M
M
Consultation and Liaison Service, Department of General Psychiatry, Innsbruck University Hospital, Austria. Martin.Kopp@uibk.ac.at
Holzner
B
B
Brugger
A
A
Nachbaur
D
D
D000328:Adult; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy / Q000209:etiology; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D003399:Craniotomy; D003865:Major Depressive Disorder / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D004322:Drainage; D006185:Habituation, Psychophysiologic; D006261:Headache / Q000209:etiology; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000523:psychology*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000523:psychology / Q000628:therapy*; D008140:Lorazepam / Q000627:therapeutic use*; D018191:Lymphangioma, Cystic / Q000209:etiology / Q000601:surgery; D008297:Male; D016584:Panic Disorder / Q000188:drug therapy / Q000209:etiology / Q000628:therapy; D010356:Patient Isolation / Q000523:psychology*; D010698:Phobic Disorders / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D012064:Relaxation Therapy
D014151:Anti-Anxiety Agents; D008140:Lorazepam